DISCOVERY
Uncover breakthrough
innovations during the drug
discovery phase.
innovations during the drug
discovery phase.
RWD and RWE for Regulatory and Health Technology Assessments
This article is based on the session “Real-World Evidence (RWE) for Regulatory and Health ...
Maximizing The Next 40 Years of The Orphan Drug Act
This article is based on the session titled, “Sustainability of Rare Disease Drug ...
Quality Equation: 4 Key Components to Enable Drug Development Success
Click Here to Watch "The Quality Equation: Four Essential Components to Enable Drug ...
Inspection Readiness Methodology: Failure to Plan is a Plan to Fail
Watch Halloran’s Inspection Readiness Webinar Here A Health Authority inspection of a ...
Future of Clinical Trials: Forging New Pathways with Artificial Intelligence
Biocom California’s first annual Converge Summit, recently held in South San Francisco, ...
Investors Follow Teams: Leadership Considerations to Enable Success
Developing a life science asset from early discovery through clinical development to ...
Raw Material Control for Biotechs (Part 2): Clinical Development Considerations
Introduction
Moving from Discovery to Commercialization in Precision Medicine
The revolution in precision medicine, a form of medicine using information about a ...
Egnyte and Lorenz Life Sciences Announce Integration Supporting Regulatory Document Management
May 7, 2024 – LORENZ Life Sciences and Egnyte today announced an integration in the ...
Rare But Not Forgotten: Opportunities in Rare Disease Drug Development
This article was co-written by Samantha Zappia, Principal Consultant, SK Regulatory ...